Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Iridex (IRIX) Research & Development (2016 - 2026)

Iridex has reported Research & Development over the past 17 years, most recently at $949000.0 for Q1 2026.

  • For Q1 2026, Research & Development fell 14.73% year-over-year to $949000.0; the TTM value through Jan 2026 reached $3.7 million, down 32.68%, while the annual FY2026 figure was $3.7 million, 32.68% down from the prior year.
  • Research & Development for Q1 2026 was $949000.0 at Iridex, down from $972000.0 in the prior quarter.
  • Over five years, Research & Development peaked at $4.5 million in Q1 2022 and troughed at $871000.0 in Q2 2025.
  • A 5-year average of $1.6 million and a median of $1.5 million in 2024 define the central range for Research & Development.
  • On a YoY basis, Research & Development climbed as much as 81.63% in 2022 and fell as far as 67.58% in 2022.
  • Year by year, Research & Development stood at $1.4 million in 2022, then increased by 16.83% to $1.7 million in 2023, then tumbled by 34.3% to $1.1 million in 2024, then decreased by 12.67% to $972000.0 in 2025, then decreased by 2.37% to $949000.0 in 2026.
  • Business Quant data shows Research & Development for IRIX at $949000.0 in Q1 2026, $972000.0 in Q3 2025, and $871000.0 in Q2 2025.